Related Experiment Videos
Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk
Insights
The Multiple Risk Factor Intervention Trial found that a special intervention program slightly reduced coronary heart disease (CHD) events in men. While not statistically significant overall, cholesterol and smoking reduction interventions showed significant benefits.
Area of Science:
- Cardiovascular Medicine
- Preventive Cardiology
- Clinical Trials
Background:
- Coronary heart disease (CHD) poses a significant public health challenge.
- Middle-aged men are a key demographic for cardiovascular disease prevention strategies.
- Identifying effective interventions for reducing CHD risk factors is crucial.
Purpose of the Study:
- To evaluate the efficacy of a special intervention (SI) program in preventing major coronary heart disease (CHD) events.
- To assess the impact of reducing serum cholesterol, blood pressure, and cigarette smoking on CHD incidence.
- To analyze the effects of specific risk factor modifications within a randomized clinical trial setting.
Main Methods:
- A randomized clinical trial involving over 12,000 middle-aged men.
- Comparison of a special intervention (SI) group with a usual care (UC) group over 7 years.
- Primary endpoint: first major CHD events (nonfatal myocardial infarction or CHD death).
- Secondary analysis of risk factor changes (cholesterol, blood pressure, smoking) and other cardiovascular endpoints.
Main Results:
- The SI group showed a slightly lower incidence of major CHD events compared to the UC group, but the difference was not statistically significant.
- Regression analyses indicated significant reductions in CHD events associated with lower cholesterol and smoking levels (p < 0.001).
- Antihypertensive treatment in the SI group did not show a clear favorable association with CHD rates.
- Other cardiovascular endpoints, including angina pectoris, congestive heart failure, and peripheral arterial disease, were less frequent in the SI group (nominally significant).
Conclusions:
- The overall trial did not achieve statistical significance in reducing major CHD events, potentially due to heterogeneous effects of interventions.
- Interventions targeting cholesterol reduction and smoking cessation demonstrated significant benefits in preventing CHD events.
- Further research is needed to understand the complex effects of antihypertensive interventions in cardiovascular risk reduction programs.
Abstract:
The Multiple Risk Factor Intervention Trial was a randomized clinical study to test whether a special-intervention (SI) program aimed at reducing serum cholesterol levels, blood pressure and cigarette smoking would prevent coronary heart disease (CHD) in middle-aged men. The main endpoint reported here is the percentage of participants experiencing first major CHD events (either nonfatal acute myocardial infarction [AMI] or CHD death) during 7 years of follow-up. This outcome was slightly less frequent in the 6,428 SI men than in the 6,438 men assigned to their usual source of care (UC). However, the relative difference--either 1% (95% confidence interval -17% to 16%) or 8% (95% confidence interval -5% to 20%), depending on how AMI was classified--was not statistically significant. Regression analyses within the SI and UC groups suggested that the cholesterol and cigarette smoking interventions reduced the number of first major CHD events: the associations between lowering the levels of these 2 factors and reductions in CHD rates were significant (p less than 0.001) and of the anticipated magnitude. A similar analysis of antihypertensive treatment in the SI group revealed no favorable association between lowering blood pressure and CHD rate, and other subgroup comparisons suggested that a mixture of beneficial and adverse effects may underlie this finding. Thus, the nonsignificant overall UC/SI contrast in CHD rates may reflect a combination of the expected beneficial effects of the cholesterol and smoking interventions with unexpected heterogeneous effects of the antihypertensive intervention. Seven of 8 other prespecified cardiovascular endpoints occurred less frequently among SI than among UC men, the difference being nominally significant (p less than 0.05) for angina pectoris, congestive heart failure and peripheral arterial disease.